Hays SJ - Search Results

1

Synthesis and pharmacological evaluation of 4a-phenanthrenamine derivatives acting at the phencyclidine binding site of the N-methyl-D-aspartate receptor complex.

Bigge CF, Malone TC, Hays SJ, Johnson G, Novak PM, Lescosky LJ, Retz DM, Ortwine DF, Probert AW Jr, Coughenour LL, et al. Bigge CF, et al. Among authors: hays sj. J Med Chem. 1993 Jul 9;36(14):1977-95. doi: 10.1021/jm00066a007. J Med Chem. 1993. PMID: 8336337

2

New and versatile approaches to the synthesis of CPP-related competitive NMDA antagonists. Preliminary structure-activity relationships and pharmacological evaluation.

Hays SJ, Bigge CF, Novak PM, Drummond JT, Bobovski TP, Rice MJ, Johnson G, Brahce LJ, Coughenour LL. Hays SJ, et al. J Med Chem. 1990 Oct;33(10):2916-24. doi: 10.1021/jm00172a037. J Med Chem. 1990. PMID: 2145436

3

Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.

Roufos I, Hays SJ, Dooley DJ, Schwarz RD, Campbell GW, Probert AW Jr. Roufos I, et al. Among authors: hays sj. J Med Chem. 1994 Jan 21;37(2):268-74. doi: 10.1021/jm00028a010. J Med Chem. 1994. PMID: 8295214

4

Synthesis and pharmacological evaluation of hexahydrofluorenamines as noncompetitive antagonists at the N-methyl-D-aspartate receptor.

Hays SJ, Novak PM, Ortwine DF, Bigge CF, Colbry NL, Johnson G, Lescosky LJ, Malone TC, Michael A, Reily MD, et al. Hays SJ, et al. J Med Chem. 1993 Mar 19;36(6):654-70. doi: 10.1021/jm00058a002. J Med Chem. 1993. PMID: 8459395

5

Substituted 2-benzothiazolamines as sodium flux inhibitors: quantitative structure-activity relationships and anticonvulsant activity.

Hays SJ, Rice MJ, Ortwine DF, Johnson G, Schwarz RD, Boyd DK, Copeland LF, Vartanian MG, Boxer PA. Hays SJ, et al. J Pharm Sci. 1994 Oct;83(10):1425-32. doi: 10.1002/jps.2600831013. J Pharm Sci. 1994. PMID: 7884664

6

Alpha-mercaptoacrylic acid derivatives as novel selective calpain inhibitors.

Wang KK, Posner A, Raser KJ, Buroker-Kilgore M, Nath R, Hajimohammadreza I, Probert AW, Marcoux FW, Lunney EA, Hays SJ, Yuen P-W. Wang KK, et al. Among authors: hays sj. Adv Exp Med Biol. 1996;389:95-101. doi: 10.1007/978-1-4613-0335-0_11. Adv Exp Med Biol. 1996. PMID: 8860998 Review. No abstract available.

7

2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.

Hays SJ, Caprathe BW, Gilmore JL, Amin N, Emmerling MR, Michael W, Nadimpalli R, Nath R, Raser KJ, Stafford D, Watson D, Wang K, Jaen JC. Hays SJ, et al. J Med Chem. 1998 Mar 26;41(7):1060-7. doi: 10.1021/jm970394d. J Med Chem. 1998. PMID: 9544206

8

A structure-activity relationship study of novel phenylacetamides which are sodium channel blockers.

Roufos I, Hays S, Schwarz RD. Roufos I, et al. J Med Chem. 1996 Mar 29;39(7):1514-20. doi: 10.1021/jm950467y. J Med Chem. 1996. PMID: 8691482

9

The design and synthesis of sulfonamides as caspase-1 inhibitors.

Harter WG, Albrect H, Brady K, Caprathe B, Dunbar J, Gilmore J, Hays S, Kostlan CR, Lunney B, Walker N. Harter WG, et al. Bioorg Med Chem Lett. 2004 Feb 9;14(3):809-12. doi: 10.1016/j.bmcl.2003.10.065. Bioorg Med Chem Lett. 2004. PMID: 14741295

10

Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.

Plummer JS, Cai C, Hays SJ, Gilmore JL, Emmerling MR, Michael W, Narasimhan LS, Watson MD, Wang K, Nath R, Evans LM, Jaen JC. Plummer JS, et al. Among authors: hays sj. Bioorg Med Chem Lett. 1999 Mar 22;9(6):815-20. doi: 10.1016/s0960-894x(99)00095-5. Bioorg Med Chem Lett. 1999. PMID: 10206542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters